Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Powder for SSI Prophylaxis in Lower Extremity Fractures in Haiti
NCT05535725Phase 4Completed
- Sponsor
- Clinique Ortos
- Start
- Oct 2019
- Primary completion
- Oct 2021
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in surgical site infection (SSI) comparing Vancomycin Powder with Standard of Care (2 arms). Primary endpoint: Occurrence of Surgical Site Infection at 12 months. Started Oct 2019; status: completed.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05535725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05535725.